LYVELSA-20MG-14 TABLETS (Finerenone 20mg) CKD Treatment
LYVELSA-20MG-14 TABLETS contain Finerenone 20mg, a prescription mineralocorticoid receptor antagonist used to reduce kidney disease progression and cardiovascular risk in CKD associated with type 2 diabetes.
LYVELSA-20MG-14 TABLETS
LYVELSA-20MG-14 TABLETS (FINERENONE 20MG): Comprehensive Guide and Benefits
Introduction to LYVELSA-20MG-14 TABLETS (FINERENONE 20MG)
LYVELSA-20MG-14 TABLETS (FINERENONE 20MG): A Non-Steroidal Mineralocorticoid Receptor Antagonist
LYVELSA-20MG-14 TABLETS contain Finerenone 20mg, a non-steroidal mineralocorticoid receptor antagonist (MRA) indicated for adults with chronic kidney disease (CKD) associated with type 2 diabetes. It is prescribed to help slow the progression of kidney damage and reduce the risk of cardiovascular complications such as hospitalization for heart failure, heart attack, and cardiovascular death.
Finerenone works by blocking the harmful effects of mineralocorticoid receptor overactivation, which contributes to inflammation and fibrosis in the kidneys and heart. This medicine is prescription-only and should be used under regular medical supervision. Blood potassium levels and kidney function should be monitored before and during treatment due to the risk of hyperkalemia.
Key Benefits of LYVELSA-20MG-14 TABLETS (FINERENONE 20MG)
Helps slow the progression of chronic kidney disease associated with type 2 diabetes.
Reduces the risk of cardiovascular death and heart failure hospitalization.
Helps preserve kidney function over time.
Reduces the risk of end-stage kidney disease in appropriate patients.
Provides targeted mineralocorticoid receptor blockade with a non-steroidal mechanism.
How LYVELSA-20MG-14 TABLETS (FINERENONE 20MG) Works
Finerenone selectively blocks the mineralocorticoid receptor, reducing inflammation and fibrosis in the kidneys and cardiovascular system. Excessive activation of this receptor contributes to progressive kidney damage and cardiovascular remodeling in patients with diabetic kidney disease. By inhibiting these harmful pathways, finerenone slows kidney function decline and reduces cardiovascular events while preserving renal and cardiac health.
Usage Instructions for LYVELSA-20MG-14 TABLETS (FINERENONE 20MG)
Take the medicine exactly as prescribed by your healthcare provider.
Swallow the tablet with water, with or without food.
Take it at the same time every day for consistent benefit.
Attend regular blood tests to monitor potassium levels and kidney function.
Do not discontinue treatment without consulting your physician.
Medicinal Advantages of LYVELSA-20MG-14 TABLETS (FINERENONE 20MG)
Clinically proven to slow CKD progression in adults with type 2 diabetes.
Reduces the risk of cardiovascular complications.
Lowers the likelihood of hospitalization due to heart failure.
Provides effective non-steroidal mineralocorticoid receptor blockade.
Supported by evidence-based treatment guidelines for diabetic kidney disease.
NOTE: LYVELSA-20MG-14 TABLETS are prescription-only medicines. Potassium levels and kidney function should be assessed before starting treatment and monitored periodically. Avoid concomitant use with strong CYP3A4 inhibitors unless specifically advised by your physician.
Off-Label Uses of LYVELSA-20MG-14 TABLETS (FINERENONE 20MG)
Although finerenone has approved indications, healthcare professionals may occasionally evaluate its use in selected patients based on emerging evidence and individual clinical circumstances.
Selected patients with non-diabetic chronic kidney disease under specialist supervision.
Research-based use in certain cardiovascular conditions.
Individualized nephrology treatment plans where clinically appropriate.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Take the medicine consistently at the same time each day.
Attend all scheduled kidney function and potassium monitoring appointments.
Avoid potassium supplements unless prescribed.
Inform your doctor about all prescription medicines and herbal supplements.
Avoid grapefruit and grapefruit juice during treatment.
Maintain a diabetes and kidney-friendly lifestyle as recommended by your healthcare provider.
Precautions
Cardiovascular Health
Finerenone helps reduce cardiovascular complications in eligible patients but should be used carefully in individuals with severe heart disease. Regular monitoring is recommended.
Liver & Kidney Function
Kidney function and serum potassium should be evaluated before starting treatment and monitored regularly. Patients with severe liver impairment require careful assessment before use.
Pregnancy & Breastfeeding
Use during pregnancy only if the potential benefit justifies the potential risk. Breastfeeding is generally not recommended during treatment unless advised by a healthcare provider.
Drug Interactions
Finerenone may interact with strong CYP3A4 inhibitors, CYP3A4 inducers, potassium supplements, potassium-sparing diuretics, ACE inhibitors, ARBs, and other medicines that increase potassium levels. Inform your healthcare provider about all medicines you take.
Existing Medical Conditions
Use cautiously in patients with hyperkalemia, severe kidney impairment, Addison's disease, liver disease, or significant electrolyte abnormalities.
Storage Instructions
Store below 30°C.
Keep the tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is LYVELSA-20MG-14 TABLETS used for?
A: It is used to reduce the progression of chronic kidney disease associated with type 2 diabetes and lower the risk of cardiovascular complications.
Q: How does LYVELSA-20MG-14 TABLETS work?
A: It blocks mineralocorticoid receptors, reducing inflammation and fibrosis that contribute to kidney and heart damage.
Q: Can I take LYVELSA-20MG-14 TABLETS with food?
A: Yes. It may be taken with or without food unless your healthcare provider advises otherwise.
Q: Why are blood tests required during treatment?
A: Blood tests help monitor potassium levels and kidney function, reducing the risk of complications such as hyperkalemia.
Q: What are the common side effects?
A: Common side effects include increased blood potassium (hyperkalemia), low blood pressure, and decreased sodium levels.
Q: Should I avoid grapefruit while taking this medicine?
A: Yes. Grapefruit and grapefruit juice should be avoided because they may increase finerenone levels and the risk of side effects.
Q: Is LYVELSA-20MG-14 TABLETS available without a prescription?
A: No. It is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Product Tags
LYVELSA-20MG-14 TABLETS, Finerenone 20mg, Finerenone Tablet, Mineralocorticoid Receptor Antagonist, Non-Steroidal MRA, Chronic Kidney Disease Medicine, CKD Treatment, Type 2 Diabetes Kidney Disease, Diabetic Kidney Disease, Kidney Protection Medicine, Cardiovascular Risk Reduction, Prescription Kidney Medicine, Hyperkalemia Monitoring, Finerenone 20mg Tablet, Renal Protection Therapy, Heart Failure Risk Reduction, LYVELSA Tablet, Prescription Finerenone, CKD Associated with Type 2 Diabetes, Kidney Health Medicine.
